AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 181 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $8,817,000 | -26.3% | 176,761 | -0.3% | 0.03% | -27.5% |
| Q1 2019 | $11,961,000 | +41.9% | 177,353 | -3.0% | 0.04% | +29.0% |
| Q4 2018 | $8,430,000 | -78.0% | 182,828 | -63.2% | 0.03% | -70.8% |
| Q3 2018 | $38,327,000 | -62.3% | 496,973 | -58.9% | 0.11% | -64.3% |
| Q2 2018 | $101,757,000 | +19.1% | 1,208,083 | +15.7% | 0.30% | +16.9% |
| Q1 2018 | $85,407,000 | +294.5% | 1,044,346 | +175.8% | 0.25% | +309.7% |
| Q4 2017 | $21,648,000 | -34.0% | 378,662 | -22.9% | 0.06% | -35.4% |
| Q3 2017 | $32,788,000 | +138.8% | 491,203 | +84.0% | 0.10% | +134.1% |
| Q2 2017 | $13,733,000 | +59.9% | 266,910 | +81.5% | 0.04% | +57.7% |
| Q1 2017 | $8,589,000 | +27.2% | 147,074 | -9.1% | 0.03% | +23.8% |
| Q4 2016 | $6,753,000 | -74.9% | 161,836 | -68.2% | 0.02% | -74.4% |
| Q3 2016 | $26,857,000 | +55.6% | 508,469 | +23.4% | 0.08% | +51.9% |
| Q2 2016 | $17,257,000 | +30.6% | 411,920 | +26.6% | 0.05% | +28.6% |
| Q1 2016 | $13,215,000 | +17.2% | 325,497 | +87.4% | 0.04% | +23.5% |
| Q4 2015 | $11,278,000 | +223.9% | 173,722 | +252.2% | 0.03% | +209.1% |
| Q3 2015 | $3,482,000 | -85.2% | 49,321 | -76.7% | 0.01% | -82.3% |
| Q2 2015 | $23,536,000 | +59.7% | 211,773 | +35.5% | 0.06% | +67.6% |
| Q1 2015 | $14,740,000 | -56.4% | 156,308 | -48.2% | 0.04% | -57.0% |
| Q4 2014 | $33,782,000 | -56.0% | 301,517 | -75.9% | 0.09% | -55.4% |
| Q3 2014 | $76,798,000 | -30.1% | 1,251,795 | -47.8% | 0.19% | +54.4% |
| Q2 2014 | $109,826,000 | +545.5% | 2,396,880 | +451.5% | 0.12% | +220.5% |
| Q1 2014 | $17,015,000 | +467.4% | 434,616 | +247.1% | 0.04% | +457.1% |
| Q4 2013 | $2,999,000 | – | 125,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |